Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC
Clinical trial NCT05339321 · UNKNOWN
Trial details
- NCT number
- NCT05339321
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2023-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.